Non-capsulated and capsulated Haemophilus influenzae in children with acute otitis media in Venezuela: A prospective epidemiological study

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Naranjo, Laura ^a   Suarez, Jose A ^a   DeAntonio, Rodrigo ^b   Sanchez, Francis ^a   Calvo, Alberto ^c   Spadola, Enza ^d   Rodríguez, Nicolás ^c   Andrade, Omaira ^c   Bertuglia, Francisca ^c   Márquez, Nelly ^c   Castrejon, Maria M ^b   Ortega Barria, Eduardo ^e   Colindres, Romulo E ^f  

^a Policlinica Metropolitana   (Venezuela)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Laboratorio Metropolitano   (Venezuela)

^d Instituto Nacional de Higiene Rafael Rangel   (Venezuela)

^e Estrada dos Bandeirantes   (Brazil)

^f GSK   (Belgium)

Author keywords

Acute otitis media; Non typeable haemophilus influenzae (nthi); Pneumococcal conjugate vaccine

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; TETRACYCLINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; FEMALE; FEVER; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MYRINGOTOMY; NONHUMAN; OTALGIA; OTORRHEA; PRESCHOOL CHILD; PROSPECTIVE STUDY; RECURRENT INFECTION; SEASONAL VARIATION; SEROPREVALENCE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VACCINATION; VENEZUELA; BACTERIAL MEMBRANE; CLASSIFICATION; EXUDATE; HAEMOPHILUS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MORAXELLACEAE INFECTION; OTITIS MEDIA; PATHOGENICITY; PNEUMOCOCCAL INFECTION;

BACTERIAL CAPSULES; CHILD, PRESCHOOL; EXUDATES AND TRANSUDATES; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; VENEZUELA;

EID: 84857000379     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-40     Document Type: Article

References (52)

1. Centers for Disease Control and Prevention (CDC) Pneumococcal diseases in children-Q&A. Centers for Disease Control and Prevention (CDC)., http://www.cdc.gov/
2. Klein JO. Otitis media. Clin Infect Dis 1994, 19:823-832. 10.1093/clinids/19.5.823, 7893865.
3. Berman S. Otitis media in developing countries. Pediatrics 1995, 96:126-131.
4. Cripps AW, Otczyk DC, Kyd JM. Bacterial otitis media: a vaccine preventable disease?. Vaccine 2005, 23:2304-2310. 10.1016/j.vaccine.2005.01.023, 15755616.
5. Block SL, Harrison CJ, Hedrick J, Tyler R, Smith A, Hedrick R. Restricted use of antibiotic prophylaxis for recurrent acute otitis media in the era of penicillin non-susceptible Streptococcus pneumoni. Int J Pediatr Otorhinolaryngol 2001, 61:47-60. 10.1016/S0165-5876(01)00550-X, 11576631.
6. Brobby GW. The discharging ear in the tropics: a guide to diagnosis and management in a district hospital. Trop Doct 1992, 22:10-13.
7. Valenzuela MT, de Quadros C. Antibiotic resistance in Latin America: A cause of alarm. Vaccine 2009, 27(Suppl 3):25-28.
8. Segal N, Leibovitz E, Dagan R, Leiberman A. Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines. Int J Pediatr Otorhinolaryngol 2005, 69:1311-1319. 10.1016/j.ijporl.2005.05.003, 15955573.
9. Arguedas A, Sher L, Lopez E, Sáez-Llorens X, Hamed K, Skuba K, Pierce PF. Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure. Pediatr Infect Dis J 2003, 22:949-956. 10.1097/01.inf.0000095193.42502.d1, 14614365.
10. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004, 23:824-828. 10.1097/01.inf.0000136871.51792.19, 15361720.
11. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenza: a significant pathogen in acute otitis media. Pediatr Infect Dis J 2004, 23:1142-1152.
12. Arguedas A, Dagan R, Soley C, Loaiza C, Knudsen K, Porat N, Perez A, Brilla E, Herrera ML. Microbiology of otitis media in Costa Rican children, 1999 through 2001. Pediatr Infect Dis J 2003, 22:1063-1068. 10.1097/01.inf.0000101189.81501.e9, 14688566.
13. Rosenblut A, Santolaya ME, González P, Corbalán V, Avendanõ LF, Martínez MA, Hormazabal JC. Bacterial and viral etiology of acute otitis media in Chilean children. Pediatr Infect Dis J 2001, 20:501-507. 10.1097/00006454-200105000-00006, 11368107.
14. Rosenblut A, Santolaya ME, Gonzalez P, Borel C, Cofre J. Penicillin resistance is not extrapolable to amoxicillin resistance in Streptococcus pneumonia isolated from middle ear fluid in children with acute otitis media. Ann Otol Rhinol Laryngol 2006, 115:186-190.
15. Pichichero ME. Evolving shifts in otitis media pathogens: relevance to a managed care organization. Am J Manag Care 2005, 11(Suppl 6):192-201.
16. Homoe P, Christensen RB, Bretlau P. Acute otitis media and age at onset among children in Greenland. Acta Otolaryngol 1999, 119:65-71. 10.1080/00016489950181963, 10219388.
17. World Health Organization Chronic suppurative otitis media: burden of illness and management options 2004. World Health Organization., http://www.who.int/pbd/deafness/activities/hearing_care/otitis_media.pdf
18. Al P, Rovers MM, Schilder AG, Verheij TJ, Hak E. Trends in doctor consultations, antibiotic prescriptions, and specialist referrals for otitis media in children: 1995-2003. Pediatrics 2006, 117:1879-1886. 10.1542/peds.2005-2470, 16740826.
19. Goossens H, Ferech M, Vander Stichele R, Elseviers M, . ESAC Project Group Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:548-549. ESAC Project Group.
20. Constenla D, Gomez E, de la Hoz FP, O' Loughlin R, Sinha A, Valencia JE, Valenzuela MT. The burden of pneumococcal disease and cost-effectiveness of a pneumococcal vaccine in Latin America and the Caribbean. , http://www.sabin.org/news-resources/publication/burden-pneumococcal-disease-and-cost-effectiveness-pneumococcal-vaccine-
21. Wirtz VJ, Dreser A, Gonzales R. Trends in antibiotic utilization in eight Latin American countries, 1997-2007. Rev Panam Salud Publica 2010, 27:219-225.
22. Yamanka N, Hotomi M, Billal DS. Clinical bacteriology and immunology in acute otitis media in children. J Infect Chemother 2008, 14:180-187. 10.1007/s10156-007-0599-3, 18574652.
23. Whitney CG, Klugman KP. Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Semin Pediatr Infect Dis 2004, 15:86-93. 10.1053/j.spid.2004.01.011, 15185191.
24. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000, 19:187-195. 10.1097/00006454-200003000-00003, 10749457.
25. O'Brien KL, Moulton LH, Reid R, Weatherholtz R, Oski J, Brown L, Kumar G, Parkinson A, Hu D, Hackell J, Chang I, Kohberger R, Siber G, Santosham M. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial. Lancet 2003, 362:355-361. 10.1016/S0140-6736(03)14022-6, 12907008.
26. Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B. Post licensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 2004, 23:485-489. 10.1097/01.inf.0000129685.04847.94, 15194827.
27. Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 2008, 26:3277-3281. 10.1016/j.vaccine.2008.03.087, 18456376.
28. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH, . Finnish Otitis Media Study Group Efficacy of a pneumococcal conjugate vaccine againstacute otitis media. N Engl J Med 2001, 344:403-409. 10.1056/NEJM200102083440602, 11172176, Finnish Otitis Media Study Group.
29. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV-7) serotypes in the United States during the era of widespread PCV-7 vaccination, 1998-2004. J Infect Dis 2007, 196:1346-1354. 10.1086/521626, 17922399.
30. Nigrovic LE, Kuppermann N, Malley R. Bacterial Meningitis Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics: Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era. Acad Emerg Med 2008, 15:522-528. 10.1111/j.1553-2712.2008.00117.x, 18616437.
31. Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumonia and non-typable Haemophilus influenza: a randomised double-blind efficacy study. Lancet 2006, 367:740-748. 10.1016/S0140-6736(06)68304-9, 16517274.
32. Danovaro-Holiday MC, Garcia S, DeQuadros C, Tambini G, Andrus JK. Progress in Vaccination against Haemophilus influenzae type b in the Americas. PLoS Med 2008, 5(4):e87. 10.1371/journal.pmed.0050087, 2292748, 18433291.
33. Horn VK, Toth C, Wegienek J. Viability of microorganisms in four swab systems. ASM 98th General Meeting 1998, C436.
34. National Committee for Clinical Laboratory Standards Performance Standards for antimicrobial susceptibility testing. M100 S19. National Committee for Clinical Laboratory Standards 2002, Villanova, Pennsylvania, National Committee for Clinical Laboratory Standards.
35. Organización Panamericana de la Salud Programa de vigilancia de los serotipos y resistencia antimicrobiana de Streptococcus pneumoniae y Haemophilus influenzae Manual de procedimientos del proyecto SIREVA II.
36. Commisso R, Romero-Orellano F, Montanaro PB, Romero-Moroni F, Romero-Diaz R. Acute otitis media: Bacteriology and bacterial resistance in 205 pediatric patients. Int J Pediatr Otorhinolaryngol 2000, 56:23-31. 10.1016/S0165-5876(00)00402-X, 11074112.
37. Arguedas A, Loaiza C, Perez A, Vargas F, Herrera M, Rodriguez G, Gutierrez A, Mohs E. Microbiology of acute otitis media in Costa Rican children. Pediatr Infect Dis J 1998, 17:680-689. 10.1097/00006454-199808000-00004, 9726340.
38. Parras MM, Martinez AG, Echaniz-Aviles G, Lazcano-Ponce E, Apolinar YC, Colindres R, Hausdorff WP. Bacterial etiology and serotypes of acute otitis media in children in Mexic [Abstract no: A-181-0010-00611]. 2009, Buenos Aires, Argentina: Presented at 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID), Source: MIS (5564557).
39. Sierra A, Lopez P, Zapata MA, Vanegas B, Castrejon MM, DeAntonio R, Hausdorff WP, Colindres RE. Non-typeable Haemophilus influenza and Streptococcus pneumonia as primary causes of acute otitis media in Colombian children: a prospective study. BMC Infect Dis 2010, 11:1-11.
40. Pichichero ME, Casey JR, Hoberman A, Schwartz R. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr (Phila) 2008, 47:901-906.
41. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004, 23:829-833. 10.1097/01.inf.0000136868.91756.80, 15361721.
42. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, Schutze GE, Kim KS, Mason EO, Wald ER. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumonia before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2005, 40:1738-1744. 10.1086/429908, 15909260.
43. Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI. Nontypeable Haemophilus influenza as a pathogen in children. Pediatr Infect Dis J 2009, 28:43-48. 10.1097/INF.0b013e318184dba2, 19057458.
44. Rodgers GL, Arguedas A, Cohen R, Dagan R. Global serotype distribution among Streptococcus pneumonia isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines. Vaccine 2009, 27:3802-3810. 10.1016/j.vaccine.2009.04.021, 19446378.
45. Bardach A, Ciapponi A, Garcia-Marti S, Glujovsky D, Mazzoni A, Fayad A, Colindres RE. Gentile A Epidemiology of acute otitis media in children of Latin America and the Caribbean: A systematic review and meta-analysis. Int J Pediatr Otorhinolaryngol 2011, doi:10.1016/j.ijporl.2011.05.014.
46. Dabernat H, Seguy M, Faucon G, Delmas C. Epidemiology of Haemophilus influenzae strains collected in 2004 in France and in vitro assessment of their susceptibility to antibiotic. Médecine et maladies infectieuses 2007, 37:320-324.
47. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124:e1-e11. 10.1542/peds.2008-3099, 2782668, 19564254.
48. Broides A, Dagan R, Greenberg D, Givon-Lavi N, Leibovitz E. Acute otitis media caused by Moraxella catarrhali: Epidemiologic and Clinical Characteristics. Clin Infect Dis 2009, 49:1641-1647. 10.1086/647933, 19886799.
49. Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Doern GV. GRASP Study Group: Antimicrobial resistance in Streptococcus pneumonia, Haemophilus influenza, Moraxella catarrhali and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents 2005, 25:148-156. 10.1016/j.ijantimicag.2004.09.016, 15664485.
50. Piglansky L, Leibovitz E, Raiz S, Greenberg D, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr Infect Dis J 2003, 22:405-413.
51. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368:1495-1502. 10.1016/S0140-6736(06)69637-2, 17071283.
52. Hausdorff WP, Hoet B, Schuerman L. Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?. BMC Pediatr 2010, 10:1-7. 10.1186/1471-2431-10-1, 2820464, 20078871.